68 -- HPV-Human Papillomavirus Vaccine

The Centers for Disease Control and Prevention (CDC), contemplates issuing a modification to subject contract to add the following vaccine manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration: Quadrivalent Human Papillomavirus types 6, 11, 16, 18 recombinant vaccine (HPV). The purchase of this vaccine is contingent on the approval in the Vaccines for Children (VFC) program by the Advisory Committee on the Immunization Practices (ACIP). To the best of our knowledge, only Merck can supply this vaccine. However, CDC will consider all responsible sources responding to this notice. All questions/concerns about this notice shall be submitted via e-mail to [email protected] . It is your responsibility to keep up with additional postings regarding this notice.